mRNA-based vaccines are advantageous because they can be relatively quicker and more cost efficient to manufacture compared to other traditional vaccine products. Lipid nanoparticles have three common purposes: delivery, self-adjuvanting… Click to show full abstract
mRNA-based vaccines are advantageous because they can be relatively quicker and more cost efficient to manufacture compared to other traditional vaccine products. Lipid nanoparticles have three common purposes: delivery, self-adjuvanting properties, and mRNA protection. Faster vaccine development requires an efficient and fast assay to monitor mRNA purity and integrity. Microchip capillary electrophoresis (MCE) is known to be a robust technology that is capable of rapid separation. Here we describe the development and optimization of a purity and integrity assay for mRNA-based vaccines encapsulated in lipid nanoparticles using commercial microchip based separation. The analytical parameters of the optimized assay were assessed and the method is a stability indicating assay. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.